This month the PNA Spotlight focuses on Dr. Brian Williams, an Assistant Professor in the Department of Neurosurgery at the University of Louisville in Kentucky. Dr. Williams earned his medical degree at Baylor College of Medicine in Houston. He then did a residency in neurological surgery at the University of Virginia in Charlottesville, then returned to Houston for a fellowship in neurosurgical oncology at MD Anderson Hospital. Dr. Williams took some questions from the PNA; and his answers are below.
This month the PNA Medical Corner features an article coauthored by a member of the PNA, Dr. Maria Fleseriu of Oregon Health and Science University in Portland, Oregon. The study looked at silent growth hormone adenomas, that can be tough to diagnose and are often found alongside a growth hormone-secreting tumor.
Pituitary. 2018 Jan 5. doi: 10.1007/s11102-017-0858-y. [Epub ahead of print]
DUBLIN, Ireland and TREVOSE, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that the Company has acquired the U.S. and Canadian rights to MACRILEN™ (macimorelin) from Aeterna Zentaris Inc. (Nasdaq:AEZS) (TSX:AEZS). On December 20, 2017, the U.S. Food and Drug Administration (FDA) granted marketing approval for MACRILEN, an oral growth hormone secretagogue (GHS) receptor agonist, to be used in the diagnosis of patients with adult growth hormone deficiency (AGHD), which affects approximately 60,000 adults in the U.S. and Canada. MACRILEN has been granted orphan drug designation in the U.S. and has patents with expiration dates through late 2027.
The Times of India recently did a feature on a longtime friend of the PNA, Dr. William Couldwell of the University of Utah, and his study of the possibility of using ultrasound waves against brain tumors, including pituitary tumors. Read more here:
An article in Healio explains the new clinical practice guidelines released by the European Society of Endocrinology, which endorse a multidisciplinary approach to treating aggressive tumors. Read more here. This article in Medicalexpress.com focuses on the role of the chemo drug.
An article in KBIA.com tells the story of Robert Wadlow, of Alton, Missouri, who died in 1940 at the age of 22. He was an acromegalic who stood 8’11”. He joined the circus for a while to make money for his family during the depression. The town has a statue dedicated to Wadlow. Read his story here: http://kbia.org/post/robert-wadlow-tallest-man-ever-turns-100#stream/0
An article on AOL.com showcases a study in the journal Proceedings of the National Academy of Sciences that found that men who take ibuprofen for months at a time can compromise their fertility. Read more here:
Knowledge is power and we believe keeping abreast of news on the research front is imperative. Each month in Highlights we feature a few of the top news stories, which you can read below. In addition, we update our website on a regular basis with the latest breaking news related to pituitary and hormonal disorders by gathering stories we think you'll be interested in from MD Linx, Medscape, MedPage Today, PubMed, Touch Endocrinology, News-Medical.net and WebMD.
Support the PNA
Support the PNA while you shop! Amazon Smile and Goodshop make donations to non profit organizations based on purchases. Click on the images below for information on how you can select the PNA as your charity and earn money for the PNA on all your online purchases.
Disclaimer: PNA does not engage in the practice of medicine. It is not a medical authority, nor does it claim to have medical expertise. In all cases, PNA recommends that you consult your own physician regarding any course of treatment or medication.
Our mailing address is:
Pituitary Network Association
P.O. Box 1958
Thousand Oaks, CA 91358
(805) 499-9973 Phone - (805) 480-0633 Fax
Email [email protected]
You are receiving this Newsletter because you have shown interest in receiving information about our activities.
If you do not want to receive any more emails from PNA, Unsubscribe.
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.